Wednesday - April 24, 2024

Category Archives: Health & Medicine

Duchenne Muscular Dystrophy Clinical Trial Updates 2024 | FDA Approvals, Therapies in Focus | Vyondys 53 (Golodirsen), Emflaza, Exondys 51, Translarna, Amondys 45, Viltepso, PF-06939926, Vamorolone

Duchenne Muscular Dystrophy Pipeline Insight Several major pharma and biotech companies such as Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, Pfizer, Santhera Pharmaceuticals/ReveraGen BioPharma, Taiho Pharmaceutical, FibroGen, Capricor, Daiichi Sankyo, Italfarmaco, Antisense Therapeutics, Solid Biosciences, among others, are actively working in … Continue reading →

Acute Myeloid Leukemia Market Outlook 2032 | Pfizer, Bristol Myers Squibb, Agios Pharmaceuticals, Abbvie, Jazz Pharmaceuticals, Astellas Pharma, Pfizer, Novartis Oncology, Daiichi Sankyo

Acute Myeloid Leukemia Market Acute Myeloid Leukemia Market has a promising outlook, with several emerging therapies in various stages of clinical development. The overall dynamics of the Acute Myeloid Leukemia market are anticipated to change in the coming years owing … Continue reading →

Multiple System Atrophy Market Outlook 2032 | H Lundbeck A/S, Theravance Biopharma, Brain Neurotherapy Bio, Inc, Ionis Pharmaceuticals, Inc., Alterity Therapeutics

Multiple System Atrophy Market Outlook 2032 In 2022, the market size of Multiple System Atrophy was highest in the US among the 7MM accounting for approximately USD 131 million that is further expected to increase by 2032. The Multiple System … Continue reading →

Cervical Dystonia Pipeline Assessment, 2024 | In-depth Insights Into the Emerging Drugs, Latest FDA Approvals, Clinical Trials, Therapies, Key Companies

Cervical Dystonia Pipeline Insight “Cervical Dystonia Pipeline Insight, 2024” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Cervical Dystonia market. A detailed picture of the Cervical Dystonia pipeline landscape is provided, which … Continue reading →

Bipolar Disorder Pipeline Assessment, 2024 | In-depth Insights Into the Emerging Drugs, Latest FDA Approvals, Clinical Trials, Therapies, Key Companies

Bipolar Disorder Pipeline Insights DelveInsight’s, “Bipolar Disorder – Pipeline Insight, 2024,” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in Bipolar Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Myotonic Dystrophy Pipeline Assessment 2024 | In-depth Insights Into the Emerging Drugs, Latest FDA Approvals, Clinical Trials, Ter, Key Companies

Myotonic Dystrophy Pipeline Insight The leading companies working in the Myotonic Dystrophy Market include Lupin, AMO Pharma, Harmony Biosciences, Avidity Biosciences, Dyne Therapeutics, Nexien BioPharma, Locana, Inc., Entrada Therapeutics, Arthex Biotech, NeuBase Therapeutics, NeuBase Therapeutics, Enzerna, Enzerna, Astellas Gene Therapies, … Continue reading →

Systemic Inflammatory Response Syndrome Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | CalciMedica, Athersys, RevImmune, CytoAgents, Inc

The Systemic Inflammatory Response Syndrome Market Forecast report offers an in-depth understanding of the Systemic Inflammatory Response Syndrome, historical and forecasted epidemiology as well as the Systemic Inflammatory Response Syndrome market trends in the 7MM. DelveInsight’s “Systemic Inflammatory Response Syndrome … Continue reading →

Hollywood’s Super Talent Audrey Star Launches Sizzling Rodeo Drive Beverly Hills Jewelry Collections and Manipulator Dominator Bio Collection©™

Audrey Star is bringing more bling along with health for everyone with the launch of her exclusive Signature collections of gold, diamond and stainless-steel jewelry. The super talented Hollywood celebrity Audrey Star is excited to announce her latest creative offerings, … Continue reading →